Danazol
This paper presents patient details from a study investigating livedoid vasculopathy and high lipoprotein (a) levels in response to danazol treatment.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This report describes an observed response to danazol in the context of livedoid vasculopathy associated with high lipoprotein(a) levels, drawing on patient details summarized from Table 1 of the referenced dermatologic therapy article. The key finding is that danazol was associated with a response in this setting where lipoprotein(a) was elevated. A major limitation is that this “Reactions Weekly” entry provides only brief case-level information and does not present detailed methods or broader study design beyond pointing to the original report. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Full text
505 characters
· extracted from
oa-doi-fallback
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
References (1)
Source provenance
- openalex
- last seen: 2026-05-11T04:00:27.769720+00:00